Clinical Trial Update: Temozolomide (TMZ) in Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating temozolomide in advanced SDH-mutant/deficient gastrointestinal stromal tumors is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Adam Burgoyne, MD, PhD | Conditions: Gastrointestinal Stromal Tumors, Sdh | Phase 2 | Status: ACTIVE_NOT_RECRUITING